Position in AZN
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$680,546
-$145,608 QoQ
Shares Held
3,589
-14.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#764
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Columbia Asset Management holds $59,491,013 across 10 Drug Manufacturers - General names. AZN ranks #7 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
110,475 | $14,196,037 | |
| 2 | JNJ |
Johnson & Johnson
|
51,192 | $13,001,232 | |
| 3 | LLY |
ELI LILLY & Co
|
8,009 | $9,606,235 | |
| 4 | ABBV |
AbbVie Inc.
|
34,525 | $8,687,871 | |
| 5 | AMGN |
Amgen Inc
|
21,458 | $7,770,370 | |
| 6 | PFE |
Pfizer Inc
|
190,168 | $4,579,245 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
3,589 | $680,546 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,985 | $377,124 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $680,546 | 3,589 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $826,154 | 4,189 | Shares | Sole | 2026-04-21 | |
| No filing history on record for this holder in this stock. | ||||||